These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 34745324

  • 1. Regulation of Tumorigenesis in Hepatocellular Carcinoma via the AKT3 Pathway in Cell Lines.
    Xing M, Xie X, Liu Z, Du X.
    Comput Math Methods Med; 2021; 2021():3267536. PubMed ID: 34745324
    [Abstract] [Full Text] [Related]

  • 2. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
    Shu G, Su H, Wang Z, Lai S, Wang Y, Liu X, Dai L, Bi Y, Chen W, Huang W, Zhou Z, He S, Dai H, Tang B.
    J Exp Clin Cancer Res; 2021 Jan 26; 40(1):45. PubMed ID: 33499874
    [Abstract] [Full Text] [Related]

  • 3. miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3.
    Nassirpour R, Mehta PP, Yin MJ.
    PLoS One; 2013 Jan 26; 8(11):e79655. PubMed ID: 24244539
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr 26; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.
    Tumour Biol; 2016 May 26; 37(5):5885-95. PubMed ID: 26589417
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R, Chen T, Niu Y, Tu K, Liu Q.
    J Exp Clin Cancer Res; 2019 May 14; 38(1):194. PubMed ID: 31088485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
    Yang H, Zheng W, Shuai X, Chang RM, Yu L, Fang F, Yang LY.
    Oncotarget; 2015 Sep 29; 6(29):27736-50. PubMed ID: 26315541
    [Abstract] [Full Text] [Related]

  • 14. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

  • 15. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J, Chen X, Hou Y, Kang G, Li Q, Xu Y.
    Biomed Pharmacother; 2018 Nov 05; 107():824-833. PubMed ID: 30142544
    [Abstract] [Full Text] [Related]

  • 16. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH, Shan H, Li D, Zhou B, Pang PF.
    Cell Biochem Funct; 2017 Mar 05; 35(2):98-104. PubMed ID: 28261837
    [Abstract] [Full Text] [Related]

  • 17. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
    Han Y, Liu Y, Fu X, Zhang Q, Huang H, Zhang C, Li W, Zhang J.
    J Physiol Biochem; 2018 Aug 05; 74(3):491-501. PubMed ID: 30006781
    [Abstract] [Full Text] [Related]

  • 18. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q, Gong L, Wang J, Tu Q, Yao L, Zhang JR, Han XJ, Zhu SJ, Wang SM, Li YH, Zhang W.
    BMC Cancer; 2016 Oct 18; 16(1):806. PubMed ID: 27756250
    [Abstract] [Full Text] [Related]

  • 19. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway.
    Liu J, Liu R, Liu Y, Li L, Cao H, Liu J, Cao G.
    Cell Cycle; 2021 Jun 18; 20(12):1134-1146. PubMed ID: 34097562
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W, Shao YJ.
    Aging (Albany NY); 2021 Aug 02; 13(15):19260-19271. PubMed ID: 34341185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.